ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,072.01
-0.86%
Dow Jones
37,999.19
-1.01%
US Dollar vs MXN
17.108
0.55%
Brent Oil
86.285
-1.15%
Bitcoin
60,275.48
-5.58%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Aclarion Inc (ACON)

  7. Aclarion Inc (ACON) Noticias

ACON Aclarion Inc

0.3036
0.0056 (1.88%)
Última actualización: 13:17:57
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Aclarion Inc ACON NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.0056 1.88% 0.3036 13:17:57
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.3001 0.295 0.3178 0.298
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
25/4/202408:14GLOBEAclarion’s Nociscan Solution to Play Key Role in..
06/3/202415:09EDGAR2Form SC 13G - Statement of acquisition of beneficial..
04/3/202407:00GLOBEAclarion Announces Publication of Compelling Peer-Reviewed..
27/2/202414:22GLOBEAclarion Announces Closing of $3.0 Million Public Offering
27/2/202413:00EDGAR2Form 8-K - Current report
27/2/202409:46EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
26/2/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
26/2/202408:15GLOBEAclarion Announces Pricing of $3.0 Million Public Offering
23/2/202410:46EDGAR2Form S-1/A - General form for registration of securities..
21/2/202416:25EDGAR2Form 8-K - Current report
21/2/202414:02EDGAR2Form S-1/A - General form for registration of securities..
06/2/202416:32EDGAR2Form S-1/A - General form for registration of securities..
05/2/202407:00GLOBEAclarion Announces Successful Financings; Plans to Launch..
01/2/202416:16EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
31/1/202416:26EDGAR2Form S-1/A - General form for registration of securities..
29/1/202405:04EDGAR2Form 8-K - Current report
23/1/202408:53EDGAR2Form 8-K - Current report
22/1/202415:48EDGAR2Form S-1 - General form for registration of securities under..
22/1/202407:00GLOBEAclarion Expands Nociscan Access Into Phoenix With Key..
17/1/202407:00GLOBEAclarion Announces Updated Product Release That Expands MRI..
12/1/202415:15EDGAR2Form SC 13G - Statement of acquisition of beneficial..
08/1/202407:00GLOBEAclarion and ATEC Execute Strategic Partnership Agreement to..
04/1/202407:01EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
04/1/202407:00EDGAR2Form 8-K - Current report
02/1/202411:00GLOBEAclarion Announces Reverse Stock Split
29/12/202305:30EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
19/12/202315:30EDGAR2Form 8-K - Current report
11/12/202315:55EDGAR2Form S-1 - General form for registration of securities under..
27/11/202307:00GLOBEAclarion Announces Key Commercial Milestone With Completion..
22/11/202315:01EDGAR2Form 8-K - Current report
16/11/202315:58EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
13/11/202305:00EDGAR2Form DEF 14A - Other definitive proxy statements
08/11/202307:00GLOBEAclarion Announces Achievement of Goal to Enroll 10 Leading..
06/11/202307:00GLOBEAclarion Expands Immediate Nociscan Access Into New York..
01/11/202315:15EDGAR2Form PRE 14A - Other preliminary proxy statements
01/11/202307:00GLOBEAclarion Presents at the NIH HEAL Initiative Fall Meeting
30/10/202316:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
25/10/202307:30GLOBEAclarion Announces Signing of Commercial Agreement With..
24/10/202307:45GLOBEAclarion Announces Nociscan® Cost-Effectiveness Poster..
23/10/202307:55EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
23/10/202306:00GLOBEAclarion Announces Signing Strategic Partnership Letter of..
23/10/202305:00EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
20/10/202314:08EDGAR2Form S-1/A - General form for registration of securities..
10/10/202314:34EDGAR2Form S-1 - General form for registration of securities under..
10/10/202307:30EDGAR2Form 8-K - Current report
02/10/202307:00GLOBEAclarion Provides Updated Investor Presentation and..
28/9/202306:48EDGAR2Form 8-K - Current report
07/9/202315:01EDGAR2Form 8-K - Current report
31/8/202315:01EDGAR2Form 8-K - Current report
25/8/202315:42EDGAR2Form 8-K - Current report

Su Consulta Reciente

NASDAQ
ACON
Aclarion
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados